Selective permeation of the blood-brain barrier as a cause of the anomalous properties of ‘atypical’ neuroleptics
- 1 June 1980
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 12 (6), 871-873
- https://doi.org/10.1016/0091-3057(80)90447-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Metoclopramide in Parkinson's diseaseClinical Pharmacology & Therapeutics, 1978
- A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugsJournal of Pharmacy and Pharmacology, 1978
- Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: Evidence for two different mechanisms of actionPsychopharmacology, 1978
- DOPAMINE RECEPTOR BLOCKING ACTIVITY OF SULPIRIDE IN THE CENTRAL NERVOUS SYSTEMThe Japanese Journal of Pharmacology, 1977
- Noncontingent displacement of catecholamines by intraventricular tyramine: Biphasic dose-response effects on self-stimulationNeuropharmacology, 1977
- Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic DrugsScience, 1976
- Increase of brain homovanillic acid level induced by metoclopramideNeuropharmacology, 1975
- Clozapine and the Dopamine Hypothesis of Schizophrenia, a Critical AppraisalPharmacopsychiatry, 1975
- Metoclopramide Induces Catalepsy and Increases Striatal Homovanillic Acid Content in MiceActa Pharmacologica et Toxicologica, 1974
- A re‐evaluation of the cellular morphology of the area postrema in view of recent evidence for a chemoreceptor functionJournal of Comparative Neurology, 1954